Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe.

Financial Disclosures: Dr Lyketsos reported having received grant support from the National Institute of Mental Health, the National Institute on Aging, the Associated Jewish Federation of Baltimore, the Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers, and Novartis; having served as a consultant or advisor for AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, and Lilly; and having received honoraria or travel support from Pfizer, Forest, GlaxoSmithKline, and Health Monitor. No other disclosures were reported.